{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:45:38Z","timestamp":1783464338124,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,7]],"date-time":"2024-01-07T00:00:00Z","timestamp":1704585600000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pan.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:04:56Z","timestamp":1670249096000},"page":"112-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The M-ANNHEIM-AiP-Activity-Score is useful for predicting relapse in patients with type 1 autoimmune pancreatitis"],"prefix":"10.1016","volume":"23","author":[{"given":"Takanori","family":"Sano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kikuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-7337","authenticated-orcid":false,"given":"Tetsuya","family":"Takikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2229-9475","authenticated-orcid":false,"given":"Akira","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-0754","authenticated-orcid":false,"given":"Shin","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5859-6770","authenticated-orcid":false,"given":"Kiyoshi","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2022.12.001_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00535-022-01891-7","article-title":"Current status of type 1 (IgG4-related) autoimmune pancreatitis","volume":"57","author":"Uchida","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S2468-1253(18)30121-3","article-title":"Advances in IgG4-related pancreatobiliary diseases","volume":"3","author":"Kamisawa","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2022.12.001_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41395-018-0146-0","article-title":"Autoimmune pancreatitis","volume":"113","author":"Nagpal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/2050640620934911","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.pan.2022.12.001_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-021-00529-y","article-title":"IgG4-related diseases of the digestive tract","volume":"19","author":"L\u00f6hr","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2022.12.001_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-022-01857-9","article-title":"Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020","volume":"57","author":"Okazaki","year":"2022","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00535-018-1434-6","article-title":"Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment","volume":"53","author":"Lee","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/gut.2007.129833","article-title":"Optimising corticosteroid treatment for autoimmune pancreatitis","volume":"56","author":"Ghazale","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.pan.2022.12.001_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13023-016-0487-y","article-title":"Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids","volume":"11","author":"Ohno","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.pan.2022.12.001_bib10","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/MPA.0000000000000633","article-title":"Assessment of the rate of decrease in serum IgG4 level of autoimmune pancreatitis patients in response to initial steroid therapy as a predictor of subsequent relapse","volume":"45","author":"Shimizu","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2022.12.001_bib11","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s10620-017-4541-y","article-title":"Autoimmune pancreatitis","volume":"62","author":"Majumder","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pan.2022.12.001_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00535-019-01658-7","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016","volume":"55","author":"Masamune","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pan.2017.10.005","article-title":"Monitoring and predicting disease activity in autoimmune pancreatitis with the M-ANNHEIM-AiP-Activity-Score","volume":"18","author":"Hirth","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2022.12.001_bib14","first-page":"26","article-title":"The ministry of health and welfare investigation Research team for intractable pancreatic disease. Clinical diagnostic criteria for autoimmune pancreatitis 2018","volume":"33","year":"2018","journal-title":"J\u00a0Jpn Pancreas Soc"},{"key":"10.1016\/j.pan.2022.12.001_bib15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.pan.2022.12.001_bib16","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/gut.2008.172908","article-title":"Standard steroid treatment for autoimmune pancreatitis","volume":"58","author":"Kamisawa","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.pan.2022.12.001_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.pan.2016.02.006","article-title":"Diagnosis, treatment and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: a multi-centre study","volume":"16","author":"L\u00f3pez-Serrano","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2022.12.001_bib18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s00535-020-01704-9","article-title":"Nationwide epidemiological survey of chronic pancreatitis in Japan: introduction and validation of the new Japanese diagnostic criteria 2019","volume":"55","author":"Masamune","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J\u00a0Diabetes Invest"},{"key":"10.1016\/j.pan.2022.12.001_bib20","article-title":"Development of an IgG4-RD responder index","volume":"2012","author":"Carruthers","year":"2012","journal-title":"Internet J Rheumatol"},{"key":"10.1016\/j.pan.2022.12.001_bib21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2022.12.001_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cgh.2006.05.017","article-title":"Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience","volume":"4","author":"Chari","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.pan.2022.12.001_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s00535-011-0393-y","article-title":"Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated\/not treated with corticosteroids","volume":"46","author":"Kubota","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.pan.2022.12.001_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/MPA.0000000000001147","article-title":"Prediction and management for relapse of type 1 autoimmune pancreatitis after initial steroid treatment: a long-term follow-up from China","volume":"47","author":"Xin","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2022.12.001_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.gastro.2010.03.054","article-title":"Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis","volume":"139","author":"Sah","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2022.12.001_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00535-016-1302-1","article-title":"Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients","volume":"52","author":"Kubota","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.pan.2022.12.001_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jhbp.541","article-title":"Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients","volume":"25","author":"Kubota","year":"2018","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.pan.2022.12.001_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/MPA.0000000000001173","article-title":"Predictive factors for autoimmune pancreatitis relapse after 3 years of maintenance therapy","volume":"47","author":"Nakamura","year":"2018","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2022.12.001_bib31","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.23543","article-title":"An international multispecialty validation study of the IgG4-related disease responder index","volume":"70","author":"Wallace","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.pan.2022.12.001_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-022-02792-z","article-title":"Clinical and pathological predictors of relapse in IgG4-related disease","volume":"24","author":"Zongfei","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pan.2022.12.001_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","article-title":"International consensus for the treatment of autoimmune pancreatitis","volume":"17","author":"Okazaki","year":"2017","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2022.12.001_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.mpa.0000250127.18908.38","article-title":"Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis","volume":"34","author":"Ito","year":"2007","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2022.12.001_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00428-010-0948-y","article-title":"Autoimmune pancreatitis-related diabetes: quantitative analysis of endocrine islet cells and inflammatory infiltrate","volume":"457","author":"Farris","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pan.2022.12.001_bib36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/en.2018-01029","article-title":"Adipocyte GR inhibits healthy adipose expansion through multiple mechanisms in Cushing syndrome","volume":"160","author":"Hayashi","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.pan.2022.12.001_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/MPA.0b013e31823bcdee","article-title":"Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance","volume":"41","author":"Hirano","year":"2012","journal-title":"Pancreas"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390322008237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390322008237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:17:58Z","timestamp":1761409078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390322008237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1424390322008237"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2022.12.001","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The M-ANNHEIM-AiP-Activity-Score is useful for predicting relapse in patients with type 1 autoimmune pancreatitis","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}